Is Ionis Pharmaceuticals, Inc. (IONS) a Promising Biotech Stock According to Wall Street Analysts
We recently compiled a list of the 12 Most Promising Biotech Stocks According to Wall Street Analysts. In this article, we ...
Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S.
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that it has entered into a license agreement under which Sobi® receives exclusive rights in countries outside the U.S., Canada and China to ...
Forbes14h
Ionis Pharmaceuticals
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. It operates through the Ionis Core and Akcea Therapeutics segments.
Le Lézard11m
Endo Launches Spatial Computing Simulator to Create a Fully Immersive Learning Environment for Hand Specialists
Endo, Inc. announced today the launch of a first-of-its-kind initiative for a pharmaceutical company: the Spatial Computing ...
Le Lézard27m
Dialogue becomes the only virtual care provider to receive Accreditation with Exemplary Standing from Accreditation Canada
Dialogue Health Technologies Inc. announced that it is the only virtual care provider to be awarded Accreditation with Exemplary Standing from Accreditation Canada, a globally recognized ...
California Healthline21h
California Healthline Daily Edition
Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.
News Medical on MSN14h
ELRIG announces Prof Rory Johnson and Dr Shalini Andersson as Keynote Speakers at Therapeutic Oligonucleotides 2025
ELRIG meeting on Therapeutic Oligonucleotides brings together esteemed scientists from academia, industry, and other members ...